Abstract
The role and science of imaging for breast cancer screening and diagnosis are in a state of constant change. Technical advancements, including iterative improvements to preexisting modalities and the development of novel imaging methods, are the underpinning of many of these advances. The expanding body of literature further defines both the applications and limitations of new and established breast imaging technology and informs changes in the role of imaging in the management of breast cancer. Increasingly personalized breast cancer treatment options have increased demand for personalized screening protocols risk analysis for specific patients and populations. These advances are not independent of each other, and they may be considered in four major categories. The first is supplemental screening, to address limitations of traditional mammography, including breast density. The second is personalized risk-based screening and recognizing that different populations require different screening regimens. The third is functional imaging and particularly the ongoing development of applications for intravascular iodinated and gadolinium-based contrast agents to identify high-risk tissue histology. Finally, breast imaging remains at the forefront of artificial intelligence (AI) research and related technologies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Duffy SW, Tabar L, Yen AM, Dean PB, Smith RA, Jonsson H, et al. Mammography screening reduces rates of advanced and fatal breast cancers: results in 549,091 women. Cancer. 2020;126(13):2971–9.
Pisano ED, Hendrick RE, Yaffe MJ, et al. Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology. 2008;246(2):376–83. https://doi.org/10.1148/radiol.24610702002.
Berg WA, Bandos AI, Mendelson EB, Lehrer D, Jong RA, Pisano ED. Ultrasound as the primary screening test for breast cancer: analysis from ACRIN 6666. J Natl Cancer Inst. 2015;108(4):djv367. https://doi.org/10.1093/jnci/djv3673. Published 2015 Dec 28
Screening mammography sensitivity, specificity, & false negative rate: breast cancer surveillance consortium; [updated 3/23/2017]. Available from: https://www.bcsc-research.org/statistics/screening-performance-benchmarks/screening-sens-spec-false-negative.
Lee CI, Chen LE, Elmore JG. Risk-based breast cancer screening: implications of breast density. Med Clin North Am. 2017;101(4):725–41. https://doi.org/10.1016/j.mcna.2017.03.005.
Brentnall AR, Cuzick J, Buist DSM, Bowles EJA. Long-term accuracy of breast cancer risk assessment combining classic risk factors and breast density. JAMA Oncol. 2018;4(9):e180174. https://doi.org/10.1001/jamaoncol.2018.0174.
Gail MH, Mai PL. Comparing breast cancer risk assessment models. J Natl Cancer Inst. 2010;102(10):665–8. https://doi.org/10.1093/jnci/djq141.
Vianna FSL, Giacomazzi J, Oliveira Netto CB, et al. Performance of the Gail and Tyrer-Cuzick breast cancer risk assessment models in women screened in a primary care setting with the FHS-7 questionnaire. Genet Mol Biol. 2019;42(1 suppl 1):232–7. https://doi.org/10.1590/1678-4685-GMB-2018-0110.
Kuhl CK, Schrading S, Strobel K, Schild HH, Hilgers RD, Bieling HB. Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. J Clin Oncol. 2014;32(22):2304–10.
Dromain C, Balleyguier C, Adler G, Garbay JR, Delaloge S. Contrast-enhanced digital mammography. Eur J Radiol. 2009;69(1):34–42. https://doi.org/10.1016/j.ejrad.2008.07.035.
Fallenberg EM, Schmitzberger FF, Amer H, et al. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation. Eur Radiol. 2017;27(7):2752–64. https://doi.org/10.1007/s00330-016-4650-6.
Ghaderi KF, Phillips J, Perry H, Lotfi P, Mehta TS. Contrast-enhanced mammography: current applications and future directions. Radiographics. 2019;39(7):1907–20.
Prionas ND, Lindfors KK, Ray S, Huang SY, Beckett LA, Monsky WL, et al. Contrast-enhanced dedicated breast CT: initial clinical experience. Radiology. 2010;256(3):714–23.
Houssami N, Lee CI, Buist DSM, Tao D. Artificial intelligence for breast cancer screening: opportunity or hype? Breast. 2017;36:31–3. https://doi.org/10.1016/j.breast.2017.09.003. Epub 2017 Sep 20. PMID: 28938172
Bush V. As we may think. The Atlantic Monthly. 1945 July.
Turing A. Computing machinery and intelligence. Mind. 1950;49:433–60.
Spyropoulos B, Papagounos G. A theoretical approach to artificial intelligence systems in medicine. Artif Intell Med. 1995;7(5):455–65. https://doi.org/10.1016/0933-3657(95)00015-x. PMID: 8547968
Paquerault S, Hardy PT, Wersto N, Chen J, Smith RC. Investigation of optimal use of computer-aided detection systems: the role of the “machine” in decision making process. Acad Radiol. 2010;17(9):1112–21. https://doi.org/10.1016/j.acra.2010.04.010. Epub 2010 Jun 3. PMID: 20605489
Lehman CD, Wellman RD, Buist DS, Kerlikowske K, Tosteson AN, Miglioretti DL. Breast cancer surveillance consortium. Diagnostic accuracy of digital screening mammography with and without computer-aided detection. JAMA Intern Med. 2015;175(11):1828–37. https://doi.org/10.1001/jamainternmed.2015.5231. PMID: 26414882; PMCID: PMC4836172
Rao VM, Levin DC, Parker L, Cavanaugh B, Frangos AJ, Sunshine JH. How widely is computer-aided detection used in screening and diagnostic mammography? J Am Coll Radiol. 2010;7(10):802–5. https://doi.org/10.1016/j.jacr.2010.05.019. PMID: 20889111
Onega T, Aiello Bowles EJ, Miglioretti DL, Carney PA, Geller BM, Yankaskas BC, Kerlikowske K, Sickles EA, Elmore JG. Radiologists’ perceptions of computer aided detection versus double reading for mammography interpretation. Acad Radiol. 2010;17(10):1217–26. https://doi.org/10.1016/j.acra.2010.05.007. PMID: 20832024; PMCID: PMC3149895
Cole EB, Zhang Z, Marques HS, Edward Hendrick R, Yaffe MJ, Pisano ED. Impact of computer-aided detection systems on radiologist accuracy with digital mammography. AJR Am J Roentgenol. 2014;203(4):909–16. https://doi.org/10.2214/AJR.12.10187. PMID: 25247960; PMCID: PMC4286296
Giger ML, Chan HP, Boone J. Anniversary paper: history and status of CAD and quantitative image analysis: the role of medical physics and AAPM. Med Phys. 2008;35(12):5799–820. https://doi.org/10.1118/1.3013555. PMID: 19175137; PMCID: PMC2673617
Breast Cancer Surveillance Consortium (BCSC). Performance measures for 1,838,372 screening mammography examinations from 2004 to 2008 by age–based on BCSC data through 2009. National Cancer Institute. 2009.
Choi E, Schuetz A, Stewart WF, Sun J. Using recurrent neural network models for early detection of heart failure onset. J Am Med Inform Assoc. 2017;24(2):361–70. https://doi.org/10.1093/jamia/ocw112. PMID: 27521897; PMCID: PMC5391725
Ha R, Chang P, Karcich J, Mutasa S, Pascual Van Sant E, Liu MZ, Jambawalikar S. Convolutional neural network based breast cancer risk stratification using a mammographic dataset. Acad Radiol. 2019;26(4):544–9. https://doi.org/10.1016/j.acra.2018.06.020. Epub 2018 Jul 31. PMID: 30072292
Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563–77. https://doi.org/10.1148/radiol.2015151169. Epub 2015 Nov 18. PMID: 26579733; PMCID: PMC4734157
Collins LC, Tamimi RM, Baer HJ, Connolly JL, Colditz GA, Schnitt SJ. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses’ Health Study. Cancer. 2005;103(9):1778–84. https://doi.org/10.1002/cncr.20979. PMID: 15770688
Sanders ME, Schuyler PA, Simpson JF, Page DL, Dupont WD. Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up. Mod Pathol. 2015;28(5):662–9. https://doi.org/10.1038/modpathol.2014.141. Epub 2014 Dec 12. PMID: 25502729; PMCID: PMC4416977
Coxson HO, Hogg JC, Mayo JR, Behzad H, Whittall KP, Schwartz DA, Hartley PG, Galvin JR, Wilson JS, Hunninghake GW. Quantification of idiopathic pulmonary fibrosis using computed tomography and histology. Am J Respir Crit Care Med. 1997;155(5):1649–56. https://doi.org/10.1164/ajrccm.155.5.9154871. PMID: 9154871
Hunninghake GW, Zimmerman MB, Schwartz DA, King TE Jr, Lynch J, Hegele R, Waldron J, Colby T, Müller N, Lynch D, Galvin J, Gross B, Hogg J, Toews G, Helmers R, Cooper JA Jr, Baughman R, Strange C, Millard M. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2001;164(2):193–6. https://doi.org/10.1164/ajrccm.164.2.2101090. PMID: 11463586
McKinney SM, Sieniek M, Godbole V, Godwin J, Antropova N, Ashrafian H, Back T, Chesus M, Corrado GC, Darzi A, Etemadi M, Garcia-Vicente F, Gilbert FJ, Halling-Brown M, Hassabis D, Jansen S, Karthikesalingam A, Kelly CJ, King D, Ledsam JR, Melnick D, Mostofi H, Peng L, Reicher JJ, Romera-Paredes B, Sidebottom R, Suleyman M, Tse D, Young KC, De Fauw J, Shetty S. International evaluation of an AI system for breast cancer screening. Nature. 2020;577(7788):89–94. https://doi.org/10.1038/s41586-019-1799-6. Epub 2020 Jan 1. PMID: 31894144
Rodriguez-Ruiz A, Lång K, Gubern-Merida A, Broeders M, Gennaro G, Clauser P, Helbich TH, Chevalier M, Tan T, Mertelmeier T, Wallis MG, Andersson I, Zackrisson S, Mann RM, Sechopoulos I. Stand-alone artificial intelligence for breast cancer detection in mammography: comparison with 101 radiologists. J Natl Cancer Inst. 2019;111(9):916–22. https://doi.org/10.1093/jnci/djy222. PMID: 30834436; PMCID: PMC6748773
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
O’Connell, A.M., Kawakyu-O’Connor, D. (2021). Emerging Technologies in Breast Cancer Screening and Diagnosis. In: Shetty, M.K. (eds) Breast & Gynecological Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-69476-0_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-69476-0_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-69475-3
Online ISBN: 978-3-030-69476-0
eBook Packages: MedicineMedicine (R0)